ZNF500 Abolishes Breast Cancer Proliferation and Sensitizes Chemotherapy by Stabilizing P53 via Competing with MDM2

The authors revealed that the ZNF500 mRNA and protein levels were higher in breast cancer tissues than those in their normal counterparts.